Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
HeartCore Enterprises, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/05/2023 |
8-K
| Appointed a new director |
| 10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"SERVICE AGREEMENT",
"COMMON STOCK PURCHASE WARRANT GATES GROUP Inc. Warrant Shares: 16, subject to Issuance Date: October 2, 2023 adjustment as set forth herein. THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, HeartCore Enterprises, Inc., a Delaware corporation, or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Trigger Date and on or prior to the close of business on the tenth anniversary of the Trigger Date but not thereafter, to subscribe for and purchase from GATES GROUP Inc., a Japanese corporation , the number of shares of capital stock of the Company as set forth above. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise ..." |
|
| 10/02/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Note Purchase Agreement By and Among HeartCore Enterprises, Inc. And ZEROSPO",
"ZEROSPO PROMISSORY NOTE Holder: HeartCore Enterprises, Inc. FOR VALUE RECEIVED, pursuant to the terms and conditions of this Promissory Note , ZEROSPO, an exempted company incorporated in the Cayman Islands , hereby promises to pay to the order of the holder named above, or registered assigns , on the Maturity Date or earlier as may be required herein, the principal amount as set forth above , and to pay interest on the outstanding Principal Amount at the rate of eight percent per annum, simple interest, in each case to the extent that this Note and the Principal Amount and any accrued interest hereunder has not been earlier repaid, and subject to the limitations herein. Interest shall commence accruing on the date hereof , computed on the basis of a 365-day year and the actual number of d..." |
|
| 03/16/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"CONSULTING AND SERVICES AGREEMENT",
"COMMON STOCK PURCHASE WARRANT Libera Gaming Operations, Inc. Warrant Shares: 2,970, subject to adjustment as set forth herein. Issuance Date: March 13, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, HeartCore Enterprises, Inc., a Delaware corporation, or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Trigger Date and on or prior to the close of business on the tenth anniversary of the Trigger Date but not thereafter, to subscribe for and purchase from Libera Gaming Operations, Inc., a Japanese corporation , the number of shares of capital stock of the Company as set forth above. The purchase price of one share of Common Stock under this Warrant s...",
"CONSULTING AND SERVICES AGREEMENT",
"COMMON STOCK PURCHASE WARRANT ICheck Co., Ltd. Warrant Shares: 39,446, subject to adjustment as set forth herein. Issuance Date: March 13, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, HeartCore Enterprises, Inc., a Delaware corporation, or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Trigger Date and on or prior to the close of business on the tenth anniversary of the Trigger Date but not thereafter, to subscribe for and purchase from ICheck Co., Ltd., a Japanese corporation , the number of shares of capital stock of the Company as set forth above. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exerci...",
"Press release of the registrant issued on March 16, 2023" |
|
| 02/07/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/06/2023 |
8-K
| Quarterly results |
| 01/17/2023 |
8-K
| Quarterly results |
| 01/17/2023 |
8-K
| Quarterly results |
| 01/12/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 12/20/2022 |
8-K
| Quarterly results |
| 11/23/2022 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi...|
Docs:
|
"9TH STOCK ACQUISITION RIGHTS ALLOTMENT AGREEMENT Heartcore Enterprises Inc. and SYLA Technologies Co., Ltd. enter into this STOCK ACQUISITION RIGHTS ALLOTMENT AGREEMENT as of November 9, 2022 concerning allotment of stock acquisition rights by the Issuer to the Holder as follows: Article 1 Allotment of Stock Acquisition Rights 1. The Issuer shall allot 5,771 9th Stock Acquisition Rights to be issued in accordance with the Terms and Conditions of Stock Acquisition Rights in Schedule pursuant to the resolution of the Shareholders’ Meeting of the Issuer as of November 9, 2022 and the resolution of the Board of Directors Meeting of the Issuer as of November 9, 2022 , to the Holder as set forth in this Agreement, in substitution for the COMMON STOCK PURCHASE WARRANT Agreement executed as of May...",
"AMENDMENT NO. 2 TO CONSULTING AND SERVICES AGREEMENT",
"CONSULTING AND SERVICES AGREEMENT",
"COMMON STOCK PURCHASE WARRANT SBC Medical Group, Inc. Warrant Shares: 27, subject to adjustment as set forth herein. Issuance Date: November 18, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, HeartCore Enterprises, Inc., a Delaware corporation, or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Trigger Date and on or prior to the close of business on the tenth anniversary of the Trigger Date but not thereafter, to subscribe for and purchase from SBC Medical Group, Inc., a Japanese corporation , the number of shares of capital stock of the Company as set forth above. The purchase price of one share of Common Stock under this Warrant shall be equal ..." |
|
| 11/18/2022 |
8-K
| Quarterly results |
| 10/26/2022 |
8-K
| Quarterly results |
| 09/08/2022 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 08/18/2022 |
8-K
| Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Financial Statements and Exh...|
Docs:
|
"AMENDMENT NO. 1 TO CONSULTING AND SERVICES AGREEMENT",
"COMMON STOCK PURCHASE WARRANT Syla Technologies Co. Ltd. Warrant Shares: 37,500, subject to adjustment as set forth herein. Issuance Date: August 17, 2022 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, Heartcore Enterprises, Inc., a Delaware corporation, or its registered assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the IPO Date and on or prior to the close of business on the tenth anniversary of the IPO Date but not thereafter, to subscribe for and purchase from Syla Technologies Co. Ltd., a Japanese corporation , the number of shares of capital stock of the Company . The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Pr..." |
|
| 08/15/2022 |
8-K
| Quarterly results|
Docs:
|
"HeartCore Enterprises, Inc. Condensed Consolidated Statements of Operations and Comprehensive Income For the three months ended June 30, 2022 2021 Revenues $ 2,670,297 $ 2,865,192 Cost of revenues 1,337,296 1,175,387 Gross profit 1,333,001 1,689,805 Operating expenses: Selling expenses 728,836 101,124 General and administrative expenses 1,850,315 1,020,842 Research and development expenses 417,228 80,025 Total operating expenses 2,996,379 1,201,991 Income from operations 487,814 Other income : Interest income 9,091 3,726 Interest expenses Other income 8,777 14,207 Other expenses Total other income 126 Income before income tax provision 487,940 Income tax expense 8,979 76,226 Net income 411,714 Less: net income attributable to non-controlling interest - 10,924 Net income attributable t..." |
|
| 06/08/2022 |
8-K
| Quarterly results |
| 05/25/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 04/06/2022 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/02/2022 |
8-K
| Quarterly results |
| 02/14/2022 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 02/14/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
|
|